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In our modern and developed nation, more people die from coronary
artery disease (CAD) and stroke than any other cause. Deaths caused by CAD
even outnumber deaths from all forms of cancer combined. It is now widely
accepted that controlling hypercholesterolemia reduces the morbidity and
mortality of CAD (Steinberg and Gotto, 1999). Data from several studies
demonstrates the need for both dietary and pharmacologic strategies to prevent
both coronary heart disease and cardiovascular disease (Stamler et al., 2000).
Therefore it is important to identify different dietary strategies for people
who need to lower their cholesterol. One such strategy is the use of selected
strains of Lactobacillus acidophilus that have been shown to lower cholesterol by
one of two different mechanisms: cholesterol assimilation (Gilliland et al., 1985)
and bile salt deconjugation (Gilliland and Speck, 1977; Brashears et al., 1998;
Corzo and Gilliland, 1999a.; Pereira et al., 2002). In a study by Danielson et al.
(1989), the cholesterol lowering effect of acidophilus yogurt was tested on mature
boars that had been fed a high cholesterol diet. The results showed a significant
decrease in the serum cholesterol in the boars fed acidophilus yogurt compared
to those in the control group.
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Another useful substance that can help lower serum cholesterol is the
soluble fiber, β-glucan, found in oats. Beta-glucan can bind both free and
conjugated bile acids which may result in their being excreted from the body
(Cuesta-Alonso and Gilliland, 2003). The body must then synthesize new bile
acids using cholesterol in the body which will in turn lower serum cholesterol.
Anderson et al. (1984) reported that hypercholesterolemic male subjects
consuming an oat bran diet had a 19% decrease in serum cholesterol
concentrations. Exocellular polysaccharides produced by some strains of
traditional yogurt starter cultures also preferentially bind free bile acids and thus
may be helpful in lowering serum cholesterol levels (Pigeon et al., 2002).
There are many positive research results for the hypocholesterolemic
effect of both L. acidophilus and β-glucan. Results of some studies also have
indicated that the combination of the two might have even more positive effects
on cholesterol levels. One reason for this is that free bile acids inhibit the bile
salt hydrolase activity of L. acidophilus (Corzo, 1997). Therefore binding of free
bile acids by β-glucan may improve the deconjugation activity of L. acidophilus
(Cuesta-Alonso and Gilliland, 2003).
The objective of this study was to determine if there was an enhanced
hypocholesterolemic effect of a combination of L. acidophilus and oat β-glucan
administered to pigs fed a high cholesterol diet. Additionally, the immune




Health Benefits from the Consumption of Probiotic Cultures
A large body of research has attributed many potential health benefits to
the consumption of probiotic bacteria. These benefits include the control of
intestinal pathogens, lactose utilization, enhanced immunity, anti-carcinogenic
properties, and control of serum cholesterol levels. The first four topics will be
covered briefly and the latter in more detail since it is the focus of this study.
Control of intestinal pathogens
Probiotic cultures such as Lactobacillus acidophilus have been shown to
inhibit intestinal pathogens in both in vitro and in vivo experiments. In a study
done by Gilliland and Speck (1977), L. acidophilus NCFM had an inhibitory effect
on the growth of Staphylococcus aureus, Salmonella typhimurium, and
Clostridium perfringens in MRS broth media. Staphylococcus aureus, S.
typhimurium, and Escherichia coli were inhibited by L. acidophilus 4962 in a milk
base medium.
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In an in vivo study by Watkins and Miller (1983) baby chicks were used to
investigate the effects of L. acidophilus on pathogenic S. typhimurium and S.
aureus. The results of the study indicated that a prophylactic treatment was
more effective in inhibiting pathogens than a therapeutic treatment. Mortality
from the pathogens was significantly (P<0.01) reduced. Shedding of both
pathogens was also significantly (P<0.01) reduced. The shedding of L.
acidophilus increased as higher numbers of L. acidophilus were used for
treatment. This decreased pathogen shedding and increased L. acidophilus
shedding indicates that the lactobacilli were able to competitively inhibit the
pathogens.
In recent research, many studies have been conducted to investigate the
efficacy of Lactobacillus direct-fed microbials for reducing E. coli O157:H7 in
feedlot cattle. Brashears et al. (2003) found that the feeding of either L.
acidophilus 747 or L. crispatus 750 resulted in a reduction of fecal shedding of E.
coli O157:H7 and hide contamination at harvest. A similar study by Younts-Dahl
et al. (2005) evaluated the effect of three different doses of L. acidophilus strain
NP51 and a combination of strains NP51 and NP45 on the prevalence of E. coli
O157:H7 in feedlot steers. The greatest decrease in E. coli O157:H7 was found
in the treatment group receiving the highest dose of L. acidophilus NP51 which
was 109 CFU per steer/day.
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Lactose utilization
People with an inability to digest lactose have an inadequate supply of the
enzyme, lactase, to hydrolyze the disaccharide in the small intestine. When
lactase deficient people consume dairy products they are plagued with several
gastrointestinal symptoms which include cramps, diarrhea, and bloating
(Cappello and Marzio, 2005). Many strains of probiotic bacteria are lactic acid
bacteria that contain β-galactosidase which enables them to metabolize lactose.
The yogurt culture, S. thermophilus, produced active β-galactosidase in the
digestive tracts of germ-free mice. The enzyme, β-galactosidase, significantly
decreased the amount of lactose recovered in the feces of mice who were given
S. thermophilus orally (Drouault et al., 2002). Other lactic acid bacteria used in
fermented products produce β-galactosidase that remains active during passage
through the digestive tract. The enzyme aids in lactose digestion in the small
intestine after being released from the bacterial cells by bile salts (De Vrese et
al., 2001).
A breath hydrogen test can be used to determine lactose malabsorption.
More hydrogen will be detected in the breath of people that are unable to utilize
lactose (Fernandes et al., 1978). Studies by Kim and Gilliland (1983) showed
that lactose malabsorbers who consumed milk containing cells of L. acidophilus
had reduced hydrogen exhalation. These results indicate that L. acidophilus aids
lactose malabsorbers in the utilization of lactose. There was, however, some
variation in the response of lactase deficient people. This dietary strategy might
not be effective for every individual with difficulties metabolizing lactose.
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Several research studies have had positive results for improved lactose
digestion by administering unfermented acidophilus milk to lactose intolerant test
subjects. The permeability of the cells of L. acidophilus increased in an
environment containing bile so that more lactose can be hydrolyzed within the
cell (Noh and Gilliland, 1993; Mustapha et al., 1997). Consumption of the
acidophilus milk significantly decreased the common symptoms associated with
lactose intolerance.
Enhanced Immunity
There are several proposed mechanisms for enhanced immunity from the
consumption of probiotics. Some of these mechanisms include: increased
intestinal permeability, altered gut microecology, intestinal immunoglobulin A
response, and the balance of pro-inflammatory and anti-inflammatory cytokines
(Isolauri et al., 2001).
Research has documented the use of probiotics to treat or prevent certain
instances of gastroenteritis and diarrhea. For example infant rotavirus diarrhea
has been treated successfully with Lactobacillus rhamnosus GG. Treatment with
this probiotic reduced the length of the diarrhea episode by almost half (Marteau
et al., 2001).
Probiotics also have been used in attempts to lessen allergic reactions.
Isolauri et al. (2000) tested a group of 27 infants who exhibited atopic eczema
during breast-feeding. The infants were assigned to one of three treatments:
hydrolyzed whey formula alone, formula supplemented with Bifidobacterium
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lactis Bb-12, or formula supplemented with Lactobacillus strain GG. The infants
receiving the probiotic-supplemented formulas showed a significant improvement
in skin condition after two months. Allergic inflammation was also reduced as
evidenced by a decrease in shedding of certain cell surface receptor proteins into
serum and eosinophilic protein X (EPX) in urine. Chronic inflammation can
cause an increase in these molecules. Allergic inflammation of childhood asthma
has been shown to be related to urinary EPX.
Enhanced Immunoglobulin Production
Enhanced immunoglobulin production by ingestion of probiotics has been
studied in both animals and humans. Link-Amster et al. (1994) studied the
effects of milk fermented with S. thermophilus, mesophilic streptococci,
bifidobacteria Bb12 (a commercial mixed culture from Chris Hansen, Hørshom,
Denmark) and containing L. acidophilus La1 on the humoral immune response of
human volunteers. The volunteers were divided into two groups. Both groups
were required to exclude fermented products from their diets two weeks prior to
the study. Group A received three 125 g portions of the fermented milk per day
for three weeks. Group B (control group) was given no fermented milk and they
continued to exclude fermented products from their diet. All volunteers were
given the attenuated Salmonella typhi Ty21a oral vaccine capsule on days 8, 10,
and 12 of the fermented milk intake phase. In Group A serum IgA increased
significantly from day 12 of the fermented foods exclusion period to 14 days after
the administration of the S. typhi Ty21a vaccine capsule. The researchers also
8
observed a >4-fold rise in specific IgA antibody titers. There were no significant
changes in serum IgG. The researchers concluded that the increase in serum
IgA response correlated well with previous research that indicated protection
from S. typhi is an IgA antibody-dependent cytotoxicity. The group receiving the
fermented milk showed an increased humoral immune response.
The ingestion of a fermented product was tested for increased immune
response in weaned pigs (Lessard and Brisson, 1987). The fermented product
was made from rehydrated skim milk powder and fermented by L. bulgaricus, L.
casei, and S. thermophilus. The finished product was freeze-dried and used as a
powder. The study design was a 2 x 3 factorial arrangement with 2 levels of
probiotic treatments: none and 0.1% of the diet and 3 levels of vaccination
treatments with transmissible gastroenteritis virus: none, intramuscular, and oral
vaccination. There were no differences observed in serum IgG or IgA levels at
weaning in pigs fed with or without the fermented product. After three weeks and
at the end of the feeding period the vaccinations were administered. At this time
the serum IgG levels were significantly higher in pigs fed the fermented product
than the pigs on the control diet. The serum IgA levels were not significantly
different.
The immune modulating effects of Lactobacillus rhamnosus HN001
(DR20TM) was evaluated in mice that had been challenged with E. coli O157:H7
(Shu and Gill, 2002). For a week before the experimental period all mice were
fed a skim milk powder-based diet (SMP-based diet) ad libitum. After this time
period the mice were randomly assigned to either the control group or L.
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rhamnosus HN001 group. There were 40 mice in the control group and 44 mice
in the L. rhamnosus HN001 group. The control group was fed the same SMP-
based diet as mentioned before. The experimental group was fed the SMP-
based diet with 3.0 x 108 cfu/g of L. rhamnosus HN001. After 7 days E. coli
O157:H7 (1.0 x 107 cfu/mouse) was orally administered to both groups of mice.
The mice were given the same diets for 7 days following the E. coli O157:H7
challenge. Following the trial 10 mice from each experimental group were used
for the analysis of several parameters. The mucosal antibody response was
measured as immunoglobulins IgA and IgG from the flushed contents of the
small intestine. There was no significant difference in IgG titers for the L.
rhamnosus HN001 and control group. The L. rhamnosus HN001 group had
significantly higher mean anti-E. coli IgA titers than the control group.
Four commercial yogurt starter cultures were tested for their immune
system effects on mice challenged with cholera toxin (Tejada-Simon et al., 1999).
Each type of yogurt was made with pasteurized nonfat milk. The four
commercial yogurt starter cultures are as follows Ultra-Gro Direct (S.
thermophilus, L. delbrueckii ssp. bulgaricus), Sbifidus Direct (S. thermophilus, L.
delbrueckii ssp. bulgaricus, L. acidophilus, Bifidobacterium spp.), PY-3 Redi-Set
(S. thermophilus, L. delbrueckii ssp. bulgaricus, L. acidophilus, Bifidobacterium
bifidum), and DPL Yogurt Quick Start ABY-2C (S. thermophilus, L. bulgaricus, L.
acidophilus, and Bifidobacterium infantis). The control diet consisted of nonfat
milk control (no starter cultures) mixed (1:1, wt/wt) with a semipurified diet while
the experimental diet had the yogurt mixed (1:1, wt/wt) with the diet. The study
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duration was 21 days. The mice were immunized with cholera toxin on day 0
and day 14. Fecal samples were collected on day 1 before immunization and
experimental feeding, 1 week after the first immunization (week 1), 2 weeks after
the first immunization (week 2), and 1 week after the second immunization (week
3) for IgA anti-cholera toxin (anti-CT) measurement. The IgA anti-CT from fecal
samples was a measure of intestinal response. Blood serum was collected 1
week after the second cholera toxin immunization to measure IgA and IgG anti-
CT antibodies. This represented a systemic response. IgA anti-CT titers from
fecal pellets were very low from day 1 samples. The levels increased slightly for
the week 1 samples but there were no significant differences among treatments.
There was a decrease in IgA anti-CT for the week 2 samples from the treatment
groups and the control group had a slightly higher level. A week after the second
dose of cholera toxin (week 3) the IgA anti-CT in the groups that received the
yogurts made with Sbifidus Direct and PY-3 Redi-Set were significantly higher
than for the controls. The Ultra-Gro Direct yogurt group had an IgA level below
that of the control. When IgA anti-CT was measured gravimetrically Sbifidus
Direct, PY-3 Redi-Set, and DPL yogurt Quick Start ABY-2C had significantly
higher levels than the control. For serum IgA anti-CT the concentrations for all
yogurt treatments except Ultra-Gro Direct were higher than the control group.
There were no significant differences among groups for IgG levels except Ultra-
Gro Direct was significantly lower than the control. The results suggest that
yogurt fermented with L. acidophilus and Bifidobacterium spp. enhanced both
mucosal and systemic IgA responses. The Ultra-Gro Direct (L. bulgaricus and S.
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thermophilus) was considered a conventional yogurt starter culture combination.
The Ultra-Gro Direct did not enhance immunoglobulin production on an intestinal
or systemic level.
Anticarcinogenic Properties
The anticarcinogenic properties of probiotics have been studied in both
human and animal models. One such animal study used male Swiss mice that
were implanted with Ehrlich ascites tumor cells (Shahani et al., 1983). The mice
were separated into the following treatments: fresh bovine colostrum, colostrum
cultured with L. acidophilus, colostrum cultured with L. bulgaricus, colostrum
cultured with L. bulgaricus and S. thermophilus, milk cultured with L. acidophilus,
and milk cultured with L. bulgaricus. The study results indicated that fresh
colostrum did not cause a significant reduction in tumor cells. There was
significant tumor inhibition in mice fed colostrum fermented with L. acidophilus, L.
bulgaricus, or S. thermophilus. There was a similar level of inhibition for whole
milk that was fermented with either L. acidophilus or L. bulgaricus. The tumor
cell inhibition by fermented colostrum or milk did not differ significantly between
the different cultures used.
Lactobacillus casei was shown to significantly prevent the recurrence of
bladder cancer in some patients (Aso et al., 1995). The product that was
administered in this study has been available in Japan for 20 years. It contains
approximately 1.0 x 1010 viable organisms per gram. The study was a double
blind design with 138 patients. The predominant theorized mechanisms for the
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success of the product include: reduction of intestinal production of carcinogens,
incorporation of carcinogens, and immune system enhancement.
Control of serum cholesterol levels
Research has shown that some strains of probiotic bacteria have a
hypocholesterolemic effect on serum cholesterol levels. Certain probiotics can
contribute to cholesterol lowering by two different mechanisms: cholesterol
assimilation and bile salt deconjugation (Liong and Shah, 2005). Studies by
Gilliland et al. (1985) revealed that some freshly isolated strains of L. acidophilus
assimilated cholesterol during growth. Studies suggest that under defined
conditions, certain strains of L. acidophilus are able to integrate steroid
structures, such as cholesterol, into the cellular structure (Noh et al., 1997). The
cholesterol assimilation was demonstrated both in vitro and in vivo. In in vitro
experiments the cholesterol assimilating strain RP32 (ATCC 43121) removed
cholesterol from MRS broth supplemented with cholesterol micelles and oxgall
(bile source). The other experimental strain, P47, did not remove cholesterol
from the media.
Both L. acidophilus RP32 (ATCC 43121) and P47 were used in a pig
feeding trial in which the pigs were being fed a high cholesterol diet. The pigs
being fed RP32 (ATCC 43121) had lower levels of serum cholesterol than did
either the control group or the group being fed P47. The cholesterol assimilating
strain, RP32 (ATCC 43121), was effective in helping to control serum cholesterol
levels while the non-cholesterol assimilating strain was not (Gilliland et al., 1985).
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Bile salt deconjugation by some strains of probiotics has also been
demonstrated experimentally. Gilliland and Speck (1977) found that human
isolates of lactobacilli varied in their ability to deconjugate the bile salts, sodium
glycocholate and sodium taurocholate. Corzo and Gilliland (1999b.) measured
the bile salt hydrolase activity of a strain of L. acidophilus using an assay
involving HPLC. Bile salt deconjugation can result in a hypocholesterolemic
effect because the free bile acids are less likely to be reabsorbed from the
intestine and are more likely to be excreted. The body must then synthesize new
bile acids from cholesterol in the body which in turn lowers serum cholesterol
levels (Brashears et al., 1998).
Danielson et al. (1989) fed 18 mature boars a high cholesterol diet for 56
days. Nine of the boars were then fed a diet that included a yogurt containing L.
acidophilus LA16. The other nine boars remained on the original diet. This
second experimental phase of the study was also 56 days in duration. The L.
acidophilus strain was originally isolated from the feces of mature boars. The
selected strain was chosen over other isolates to use in the study because it
exhibited the highest cholesterol reduction in laboratory media. The feeding trial
resulted in a 10.5% reduction in serum cholesterol for the 9 boars on the yogurt
diet (P<0.01). Neither serum high density lipoprotein (HDL) cholesterol nor
serum triglycerides were significantly affected. Serum low density lipoprotein
(LDL) cholesterol levels were decreased by 9% (P<0.08).
A decrease in serum cholesterol was also achieved in a human feeding
trial. Lactobacillus acidophilus L1 was isolated from humans and selected for its
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bile tolerance, bile salt hydrolysis, and cholesterol assimilation. The fermented
milk containing L. acidophilus L1 reduced serum cholesterol by 2.4% in the first
study and 3.2% in the second study. The combined analysis of both studies
showed a 2.9% reduction in serum cholesterol. There is a 2 to 3% reduction for
the risk for coronary heart disease for every 1% reduction of serum cholesterol.
So the findings of these studies translate into a possible 6 to 10% reduced risk
for heart disease with the consumption of an active strain of L. acidophilus
(Anderson and Gilliland, 1999).
Selection of Probiotic Strains
There are several factors to consider when a potential probiotic strain is
being selected. In order for a probiotic strain to confer any benefit to the host
organism, it is generally accepted that it must be able to grow and/or function in
the intestinal tract. A probiotic strain that is most likely to be able to do this must
exhibit the following attributes: acid tolerance, bile tolerance, and ability to
compete with similar bacteria (Gilliland and Walker, 1990; Pereira and Gibson,
2002).
Bile Tolerance
Bacteria that are selected as probiotics need to have some degree of acid
and bile tolerance in order to survive the gastrointestinal tract (Chou and Weimer,
1999; Liong and Shah, 2005). A study conducted by Gilliland et al. (1984)
investigated the ability of two strains of L. acidophilus with differing levels of bile
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tolerance to grow in the intestinal tract of dairy calves. The strain of L.
acidophilus with the highest degree of bile tolerance had the most growth in the
upper small intestines of the calves. An increase in the colonization of probiotics
in the upper intestine might be important for controlling the proliferation of
intestinal pathogens as they enter the intestinal tract (Gilliland et al., 1984).
The degree of bile tolerance of a potential probiotic also has been found to
be important for the improvement of lactose digestion by lactose intolerant
individuals. Research has shown that the permeability of L. acidophilus cells is
increased in the presence of bile. Increased permeability allows more substrate
to enter cells so that the β-galactosidase activity of the whole cell is increased
(Noh and Gilliland, 1993). Additional studies have supported these findings.
Mustapha et al. (1997) found that the L. acidophilus strain with the lowest β-
galactosidase and lactose transport activity but the highest bile tolerance was the
best strain for improving lactose digestion.
Ability to Assimilate Cholesterol
Some strains of probiotics may have a hypocholesterolemic effect upon
the host by one or both of their cholesterol lowering properties. Both cholesterol
assimilation and deconjugation of bile salts can result in the reduction of serum
cholesterol. Lactobacillus acidophilus RP32 (ATCC 43121) has been shown to
assimilate cholesterol in both in vitro and in vivo experiments (Gilliland et al.,
1985).
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Lactobacillus acidophilus RP32 (ATCC 43121) removed cholesterol from
laboratory media when grown anaerobically and in the presence of bile. It also
has been shown to deconjugate bile acids (Corzo and Gilliland, 1999a.). The
ability to assimilate cholesterol was an important factor in enabling L. acidophilus
RP32 (ATCC 43121) to control serum cholesterol in pigs (Gilliland et al., 1985).
In a study by Noh et al. (1997), most of the cholesterol assimilated by L.
acidophilus ATCC 43121 (RP32) was recovered. Lactobacillus acidophilus
ATCC 43121 (RP32) was able to assimilate cholesterol with controlled pH at 6.0
and also with no pH control. Some of the assimilated cholesterol was recovered
from the membranes of cells grown under both pH conditions. It also was
demonstrated that using unsaturated or saturated fatty acids in the phospholipids
did not affect the amount of cholesterol assimilated.
Liong and Shah (2005) reported that cholesterol can be removed from
laboratory media by growing, resting, or dead cells of several strains of
lactobacilli. There were seven strains of L. casei and four strains of L.
acidophilus used in this study. All of the strains were of human origin. Growing
cells of lactobacilli removed cholesterol ranging from 4.53 to 16.03 mg/g of dry
weight. The amount of cholesterol removed by heat-killed and resting lactobacilli
cells was not significantly different but most strains exhibited higher cholesterol
removal in the resting state. The heat-killed and resting cells removed
cholesterol ranging from 0.79 to 3.82 mg/g of dry weight.
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Bile Salt Deconjugation
Some strains of probiotics have the ability to deconjugate bile salts. This
deconjugation coupled with a decrease in pH by the acid production of the
bacteria is thought to cause the precipitation of free bile salts and cholesterol.
The solubility of bile salts decreases at a pH of 6.0 or less (Brashears et al.,
1998).
Gilliland and Speck (1977) investigated different growth conditions that
affect bile salt deconjugation. They found that L. acidophilus requires a low O/R
potential in order to deconjugate bile salts. A greater amount of deconjugation
was observed when the culture was grown in MRS broth supplemented with
thioglycollate compared to decongugation when grown in MRS broth in a GasPak
system. Gilliland and Speck (1977) also tested the deconjugating abilities of
lactobacilli isolated from human feces. They observed differences in the
deconjugation of taurocholate and glycocholate by the different strains. Some
strains deconjugated both bile salts, others deconjugated one of the two bile
salts, and some deconjugated neither.
Walker and Gilliland (1993) conducted a study to test the relationships
between the bile tolerance, cholesterol assimilation, and bile acid deconjugation
of 19 different cultures of L. acidophilus. They found that most of the strains of L.
acidophilus that assimilated cholesterol also deconjugated bile acids. However,
the correlations among the amount of cholesterol assimilation, deconjugation,
and bile tolerance were not significant.
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De Rodas et al. (1996) conducted a feeding trial to determine the
cholesterol lowering effects of L. acidophilus RP32 (ATCC 43121) and calcium
on diet induced hypercholesterolemia. The pigs were fed a diet supplemented
with 0.5% crystalline cholesterol and 10% butter for 14 days in order to increase
total serum cholesterol. On average the cholesterol was increased from 84.5 to
294.6 mg/dl in 92 kg barrows. The diets of the pigs were then supplemented with
1.4% calcium and/or 2.5 x 1011 cfu/g of L. acidophilus RP32 (ATCC 43121) per
feeding. The results of this study indicate that both the L. acidophilus and dietary
calcium have hypocholesterolemic properties. The L. acidophilus likely helped to
lower the serum cholesterol levels by cholesterol assimilation and bile salt
deconjugation. The reductions in serum cholesterol caused by the lactobacilli
were associated with increased levels of free bile salts in the serum. This
suggests the involvement of deconjugation in the cholesterol lowering effect.
Corzo and Gilliand (1999a.) conducted studies to test the bile salt
hydrolase activities of three strains of L. acidophilus. Two of the strains in the
study were of human origin and the third strain was of porcine origin. Bile salt
deconjugation of the cultures was tested on both sodium taurocholate and
sodium glycocholate with and without pH control. All three of the strains showed
deconjugation activity when grown without pH control in MRS broth that was
supplemented with both sodium glycocholate and taurocholate. The three strains
were then grown in MRS broth with pH maintained at 6.5 and supplementation of
a 2.3 molar ratio of sodium taurocholate to sodium glycocholate. This ratio of bile
salts is thought to be similar to that of a healthy human. All three strains of L.
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acidophilus displayed deconjugation activity. ATCC 43121 (RP32) deconjugated
more sodium glycocholate than the other strains and all three strains
deconjugated more sodium glycocholate than sodium taurocholate. Control of
pH at 6.5 was used to simulate the conditions in human intestines.
Klaver and van der Meer (1993) conducted research studies to investigate
what they term as the “proposed assimilation of cholesterol”. The researchers
obtained L. acidophilus RP32 (ATCC 43121) from Oklahoma State University.
The other bacterial cultures used in the study were L. casei MUH117, L.
acidophilus MUH79, L. acidophilus MUH41, Bifidobacterium bifidum MUH80, and
L. acidophilus CH1. The study involved both pH-controlled and acidifying
conditions. The researchers concluded that bile salt-deconjugating activity of L.
acidophilus RP32 (ATCC 43121) was responsible for the disappearance of
cholesterol from the growth medium. All of the other strains tested were shown
to deconjugate bile acids except for L. acidophilus CH1 and L. casei MUH117.
When comparing studies of germ-free and normal microflora animals it is
evident that the gut microflora has an impact on the metabolism. Germ-free
animals have been shown to excrete only conjugated bile acids. Some of the
intestinal bacteria of normal microflora animals can deconjugate primary bile
acids to form secondary bile acids. Transformation of bile acids causes a
decrease in the bile acid pool because some deconjugated bile acids may be
excreted more readily. The body must use its stores of cholesterol to synthesize
more bile acids (Eyssen, 1973).
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Host Specificity
While there may be some exceptions, for the most part probiotics exhibit
host specificity. In an in vitro study by Barrow et al. (1980), aside from two
chicken isolates, only strains from domestic pigs and wild boars were able to
adhere to the pig squamous epithelial cells. Danielson et al. (1989) also utilized
porcine strains of L. acidophilus for a pig feeding trial to avoid host specificity
complications. Due to host specificity, attention needs to be given to the
selection of strains of lactobacilli for different species of hosts (Gilliland et al.,
1975).
Health Benefits of Oat β-glucan
Control of Serum Cholesterol
Soluble fibers such as β-glucan can bind bile salts which may prevent
them from being reabsorbed by the body during enterohepatic circulation. The
bile salts that have been bound are more likely to be excreted by the body
through the feces. The body must then use some of its stores of cholesterol to
synthesize bile salts to replace those lost to excretion. This action may ultimately
cause a reduction in levels of serum cholesterol (Lia et al., 1995).
There are several proposed mechanisms for the cholesterol lowering
action of oat β-glucan. First, studies investigating the consumption of oat bran
have shown an increase in fecal bile acid excretion (Kirby et al., 1981; Anderson
et al., 1991; Lia et al., 1995; Amundsen et al., 2003). Second, the microflora of
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the colon ferment oat bran to produce the short-chain fatty acids acetate,
propionate, and butyrate (Anderson et al., 1991). Propionate may cause an
inhibition of cholesterol synthesis by the liver (Wright et al., 1990; Chen et al.,
1984). Third, diets with more soluble fiber may cause a decrease in insulin
secretion. Decreased insulin secretion may result in decreased cholesterol
synthesis because insulin is responsible for stimulating HMG-CoA reductase.
This enzyme is the rate limiting step for cholesterol production in the liver
(Jenkins et al., 1989). A fourth cholesterol lowering property of soluble fibers is
the viscosity. Beer et al. (1995) found increased gut viscosity to be a very
important factor in lowering serum cholesterol. The increase in viscosity may
form a barrier that hinders bile acid reabsorption.
The soluble fiber β-glucan may also help enhance the cholesterol lowering
capabilities of some probiotics. Some strains of L. acidophilus deconjugate bile
salts and in turn aid in lowering serum cholesterol. An accumulation of
deconjugated bile salts may cause a feedback inhibition of bile salt hydrolase,
which is responsible for deconjugation (Corzo, 1997). Therefore the addition of a
soluble fiber to bind the free bile salts may enhance the deconjugation activity of
some strains of L. acidophilus (Cuesta-Alonso and Gilliland, 2003).
Source of fiber and other benefits
The source of β-glucan for the present study was derived from oats. The
product used was actually oat bran called OatWell 22 (Oat Ingredients, Boulder,
CO). This particular oat bran contains 22% β-glucan.
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Aside from lowering cholesterol, the soluble fiber, β-glucan, has many
other beneficial properties. Brennan and Cleary (2005) have summarized the
uses and benefits of β-glucan as a functional food ingredient. Dietary fiber with
β-glucan can help reduce bowel transit time, prevent constipation, and reduce
the risk of colorectal cancer. Beta-glucan fiber can also help regulate blood
glucose levels, result in the production of short chain fatty acids, and it can act as
a prebiotic to help support the growth of helpful gut microflora.
The Pig as a Human Model
Pigs have been used as a human model for many different research
applications. It is possible to use swine because of their key similarities to
humans. These similarities include a comparable digestive tract, cardiovascular
system, and an omnivorous diet (Cevallos et al., 1979; Miller and Ullrey, 1987).
The pig is an important model for many human nutritional applications.
The physiological and anatomical aspects of the pig digestive tract greatly
resemble those of man (Miller and Ullrey, 1987). Pigs can be used as a model
where it might be unethical to use humans such as research for infant nutrition
(Burrin, 2001). Pigs and humans have main bile acids that are hydrophilic as
opposed to hydrophobic. Humans and pigs also both form “cholesterol-
supersaturated bile” (J.T. Yen, 2001).
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The objective of the present study was to determine the effects of
Lactobacillus acidophilus RP32 (ATCC 43121) and oat β-glucan on the serum
cholesterol levels in pigs on a high cholesterol diet. Additionally the immune
enhancing capabilities of L. acidophilus RP32 (ATCC 43121), Streptococcus
thermophilus OSU-1, and a combination of the cultures was tested. Twelve
crossbred gilts and twelve crossbred barrows were placed in individual pens.
Following a one week adjustment period on a corn-based diet four pigs were
randomly assigned to each of six treatments (two gilts and two barrows per
treatment): 1) control milk, 2) control milk + L. acidophilus RP32 (ATCC 43121),
3) milk fermented with S. thermophilus OSU-1, 4) milk fermented with S.
thermophilus OSU-1 + L. acidophilus RP32 (ATCC 43121), 5) 5 g oat bran
(Oatwell 22) on surface of feed + control milk, and 6) 5 g oat bran (Oatwell 22) on
surface of feed and control milk + L. acidophilus RP32 (ATCC 43121). Day 0
blood samples were taken for baseline cholesterol levels and the pigs were
placed on a high cholesterol diet. The pigs were fed the corn based diet with
1,761 mg cholesterol per kg feed for 14 days. On day 7 and day 14 blood
samples were taken and analyzed for total serum cholesterol. Pigs that were
given treatments 1, 2, 3, and 4 were inoculated with lipopolysaccharide (LPS)
derived from enteropathogenic Escherichia coli O111:B4. Temperature and
serum IgG, IgA, and IgM were measured at 0, 1.5, 3.0, and 6.0 hours. Enzyme
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linked immunosorbent assays (ELISA) were used for the immunoglobulin
analyses. Results for the cholesterol feeding trial were highly variable. The
control milk containing L. acidophilus RP32 (ATCC 43121) caused a significant
decrease in cholesterol from day 7 to day 14 in the animals having an initial
mean cholesterol level of 85 mg/dl. There were no other significant decreases in
cholesterol observed. Immunoglobulins IgG and IgA were both increased by L.
acidophilus RP32 (ATCC 43121) and S. thermophilus OSU-1 when given
separately. However, the combination of the cultures did not result in a




High serum cholesterol levels have been associated to coronary heart
disease (CHD) (Cleeman and Lenfant, 1998). Of both males and females, an
estimated one in four have some type of cardiovascular disease (CVD). In 2002,
38% of all deaths were attributed to CVD a disease which cost an estimated
$393.5 billion in 2005 (American Heart Association, 2005). Hypercholesterolemia
and more specifically elevated LDL cholesterol have been identified as major
risks for CVD (Levy, 1981; Schaefer, 2002). Because of all of these factors it is
imperative to identify different tactics to help lower serum cholesterol levels.
One strategy for lowering serum cholesterol levels that has been identified
through research is the ingestion of products containing active cultures of
Lactobacillus acidophilus (Gilliland et al., 1985; Danielson et al., 1989; Anderson
and Gilliland, 1999). In vitro laboratory experiments are useful for identifying
strains of L. acidophilus that possess the characteristics for both survival in the
gastrointestinal tract and hypocholesterolemic traits. Potential probiotic strains of
L. acidophilus should be bile tolerant, acid tolerant, and competitive against
intestinal flora (Gilliland and Walker, 1990; Pereira and Gibson, 2002). Probiotic
strains intended for cholesterol reduction also demonstrate the ability to remove
cholesterol from laboratory media. Cholesterol removal by selected strains of L.
acidophilus is thought to be achieved by way of one or both of the following
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mechanisms: cholesterol assimilation and bile salt deconjugation (Liong and
Shah, 2005).
In vitro experiments showed the uptake of cholesterol from laboratory
media when the culture was grown in the presence of bile and anaerobically
(Gilliland et al., 1985). Certain strains of L. acidophilus can also deconjugate bile
salts under anaerobic conditions (Gilliland and Speck, 1977). Bile salt hydrolase
is the enzyme responsible for bile salt deconjugation (Corzo and Gilliland, 1999).
Both of the previously mentioned actions can be involved in reducing serum
cholesterol levels.
Another well documented cholesterol-lowering agent is the soluble oat
fiber (β-glucan). Anderson et al. (1984) reported that consumption of an oat bran
diet by hypercholesterolemic male subjects caused a 19% decrease in serum
cholesterol concentrations. Amundsen et al. (2003) reported the cholesterol
lowering effect of a diet supplemented with oat bran concentrate (OBC).
Subjects on the OBC diet had a significant decrease in serum cholesterol and
low-density lipoprotein compared to those in a control group.
Increased bile acid excretion is the mechanism most commonly identified
for the cholesterol reducing properties of oat β-glucan (Kirby et al., 1981;
Anderson et al., 1991; Lia et al., 1995; Amundsen et al., 2003). The proposed
cholesterol-lowering mechanisms of β-glucan other than bile acid excretion are
as follows. First, lipoprotein metabolism may be changed due to the
consumption of oat bran (Anderson et al., 1991). Second, microorganisms in the
colon ferment oat bran to produce short-chain fatty acids such as acetate,
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propionate, and butyrate (Anderson et al., 1991). These short-chain fatty acids
can decrease the cholesterol synthesis rates in rats (Hara et al., 1999). Similar
studies with rats show that propionate significantly reduced cholesterol synthesis
in the liver (Chen et al., 1984; Wright et al., 1990). Third, oat bran has been
shown to decrease insulin secretion which may reduce cholesterol synthesis
(Anderson et al., 1991). A fourth aspect of cholesterol-lowering fibers is
viscosity. A study using oat gum by Beer et al. (1995) concluded that increased
viscosity in the gut may be the most important quality of β-glucan for lowering
serum cholesterol.
A combination of all of the hypocholesterolemic mechanisms of both L.
acidophilus and oat β-glucan may enhance the cholesterol lowering effects. An
accumulation of free bile salts causes feedback inhibition for the bile salt
hydrolase enzyme of L. acidophilus (Corzo, 1997). Therefore the binding of free
bile salts by β-glucan could prevent feedback inhibition and allow the maximum
deconjugating ability of L. acidophilus (Cuesta-Alonso and Gilliland, 2003).
The objective of this study was to investigate the hypocholesterolemic
effect of a combination of both L. acidophilus and oat β-glucan fed to pigs on a
high cholesterol diet. The pig was used as a human model because of its
omnivorous diet and comparable digestive tract and cardiovascular systems
(Cevallos et al., 1979; Miller and Ullrey, 1987). A second objective was to
determine if L. acidophilus and/or fermented milk fed to pigs would influence the
levels of IgA, IgG, and IgM formed in response to a lipopolysaccharide challenge.
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MATERIALS AND METHODS
Source and Maintenance of Cultures
Lactobacillus acidophilus RP32 (ATCC 43121) and S. thermophilus OSU-
1 were both acquired from the food microbiology culture collection at Oklahoma
State University. Their identities were confirmed by Gram stain, catalase test,
growth at 15°C and 45°C plus the API 50 CH system (bioMérieux sa, France) as
described by Yap and Gilliland (2000). The fermentation patterns were
confirmed using the 9th edition of Bergey’s Manual of Determinative Bacteriology
(Sneath et al., 1986).
Each week L. acidophilus RP32 (ATCC 43121) was subcultured using a
1% inoculum into 10 ml of sterile MRS broth (Difco Laboratories, Detroit, MI).
The culture was incubated at 37°C for 18 hrs. The S. thermophilus OSU-1 was
subcultured weekly using a 1% inoculum into 10 ml of sterile nonfat milk made
with 10% non-fat dried skim milk and deionized water. This culture was
incubated in a water bath at 45°C for 18 hrs. Both cultures were subcultured
three times in their respective media before use in the feeding trial. The cultures
were stored at 4°C between subculturing procedures.
Tests for the Enhancement of Cholesterol Assimilation
In vitro tests were conducted to investigate the enhancement of
cholesterol assimilation by L. acidophilus RP32 (ATCC 43121) with added β-
glucan from Oatwell 22 oat bran (Oat Ingredients, Boulder, CO). Cholesterol-
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phosphatidylcholine micelles were prepared as described by Razin et al. (1980).
A β-glucan solution was prepared by adding 0.5 g Oatwell 22 oat bran to 10 ml
deionized water and vortexing for 30 seconds. The mixture was then centrifuged
for 10 min. at 15,000 x g and 1-3°C. The supernatant was filter sterilized through
a 0.45 µm filter (Fisher Scientific, Waltham, MA) into a sterile container and
stored in the refrigerator until use. The prepared β-glucan solution contained
approximately 5,000 µg β-glucan/ml (based on solids determination for the filtrate
using an oven drying method). The MRS-thio broth used in this experiment was
MRS broth supplemented with 0.2% sodium thioglycollate (Sigma Chemical Co.,
St. Louis, MO) and 0.3% Oxgall (Difco Laboratories, Sparks, MD). Cholesterol
assimilation was tested with and without added β-glucan. One ml of cholesterol-
phosphatidylcholine micelles and 1 ml β-glucan solution (or 1 ml sterile deionized
water) were added to 10 ml tubes of MRS-thio + oxgall broth. A freshly prepared
MRS broth culture of L. acidophilus RP32 (ATCC 43121) was used to inoculate
(1%) both tubes. Uninoculated controls with and without β-glucan were also
prepared and used. The tubes were incubated for 16 hours at 37°C. The cells
were then removed by centrifugation for 10 min. at 15,000 x g and 1-3°C. The o-
phthalaldehyde method by Rudel and Morris (1973) was used to determine the
amount of cholesterol in the spent broth both with and without β-glucan and in
the uninoculated controls. The amount of cholesterol assimilated was calculated
as the difference between the amounts in each spent broth and its corresponding
uninoculated control.
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Tests for the Enhancement of Bile Salt Deconjugation
In vitro tests were conducted to investigate the influence of β-glucan
(Oatwell 22 oat bran; Oat Ingredients, Boulder, CO) on bile salt deconjugation by
L. acidophilus RP32 (ATCC 43121). The methods for testing a culture’s ability to
deconjugate sodium taurocholate were used as described by Walker and
Gilliland (1993). The assay measures the amount of free cholic acid released by
the culture. Bile salt deconjugation with and without added β-glucan solution was
tested. A volume of 2 ml of β-glucan solution (final concentration of 500 µg β-
glucan/ml) and 2 ml of 0.01 M sodium taurocholate (final concentration of 538 µg
sodium taurocholate/ml) were added to 16 ml of MRS-thio described in the
previous section. A volume of 2 ml of sterile water in place of β-glucan was
added to a second tube. A 1% inoculation from a freshly prepared MRS broth
culture of L. acidophilus RP32 was added to each tube. An uninoculated control
for each treatment also was assayed. The amount of cholic acid released was
determined by the difference in the inoculated treatment and its corresponding
uninoculated control. The tubes were incubated for 16 hours at 37°C followed by
collection of spent media and assay for cholic acid (Walker and Gilliland, 1993).
Feeding Trial
Twelve crossbred gilts and twelve crossbred barrows (4 replicates of 6
pigs) were placed into separate pens. For the first week the pigs were fed a
corn-based diet twice daily (Table 1). Uneaten feed was cleaned out of the
feeders before each feeding. After a one week adjustment period the pigs were
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randomly assigned to 1 of 6 treatments (equal numbers of barrows and gilts in
each). The treatments are as follows: 1) control milk (25 ml), 2) control milk +
cells of L. acidophilus (25 ml), 3) control milk fermented with S. thermophilus
OSU-1 (25 ml), 4) control milk fermented with S. thermophilus OSU-1 + cells of L.
acidophilus RP32 (25 ml), 5) 5 g oat bran (Oatwell 22) on surface of feed +
control milk (25 ml), and 6) 5 g oat bran (Oatwell 22) on surface of feed and
control milk + cells of L. acidophilus RP32 (25 ml). (The treatment assignments
for each pig are in Table 2 in the Appendix). The pigs received 25 ml of their
respective treatments once daily for 14 days.
Following the adjustment period all of the pigs were placed on a high
cholesterol corn-based diet containing 1761 mg cholesterol per kg of diet for 14
days. The diet contained 0.16% crystalline cholesterol (Sigma-Aldrich, Co., St.
Louis, MO) as well as 7.5% butter which resulted in a total 1,761 mg
cholesterol/kg of diet (Table 1). For the first week the gilts and barrows were fed
an average of 0.383 kg and 0.385 kg per meal respectively. The gilts and
barrows consumed 0.313 kg and 0.344 kg feed per meal respectively. For the
second week the gilts and barrows were fed an average of 0.357 kg and 0.379
kg per meal respectively. Feed intakes for the second week were 0.313 kg per
meal for the gilts and 0.344 kg per meal for the barrows. (Feed intakes and feed
efficiencies are listed in Table 16 in the Appendix). For both weeks any uneaten
feed was removed from the feeders prior to feeding. The uneaten feed was
collected and weighed weekly to calculate feed intakes and feed efficiency.
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The control milk was dried skim milk (10%) reconstituted with deionized
water. After reconstitution it was dispensed in 125 ml volumes into bottles,
heated at 100°C for 30 min, and then refrigerated until use. A fresh milk culture
of S. thermophilus OSU-1 was used to inoculate (2%) milk for treatments 3 and
4. The bottles were incubated for 6 to 8 hours (until firm coagulation) in a 45°C
water bath.
Frozen concentrated cultures of L. acidophilus RP32 were prepared as
described by Gilliland and Rich (1990). The number of viable organisms in the
frozen concentrated cultures was confirmed by plating appropriate dilutions on
MRS agar (Difco Laboratories, Sparks, MD). Plates were incubated 48 hr at
37°C. The required number of frozen vials (2g) of concentrated culture were
thawed and added to milk for treatments 2, 4 (after fermentation), and 6. One
vial of culture (7.0 x 1010 cfu) was added to each 125ml treatment bottle just prior
to feeding pigs (each pig received 25 ml of treatment containing 1.4 x 1010 cfu).
The β-glucan utilized in the trial was from oat bran with a high percentage
of β-glucan. The commercial product called OatWell 22 was obtained from Oat
Ingredients (Boulder, CO). It contained 22% β-blucan.
Blood Collection and Cholesterol Analyses
Blood samples for all 24 pigs were collected on days 0, 7, and 14. The
day 0 samples represent the baseline cholesterol level before the pigs were
consuming the high cholesterol diet. All blood samples were taken following a 12
39
hr fast. Blood was drawn via the anterior vena cava using sterile vacutainers.
The blood was placed on ice after collection and then refrigerated overnight.
The blood samples were centrifuged for 10 min. at 3,000 x g and 1-2°C in
order to separate the blood serum. The serum was recovered by using a transfer
pipet and dispensed into 3 cryogenic vials per sample. The recovered serum
was held in a freezer (-20°C) until all of the samples for days 0, 7, and 14 had
been collected.
All blood serum samples were analyzed for total cholesterol, HDL
cholesterol, LDL cholesterol, and triglycerides at the Stillwater Medical Center
using a Vitros 5,1 FS Chemistry System (Ortho-Clinical Diagnostics, Raritan, NJ).
Escherichia coli Lipopolysaccharide (LPS) Challenge to Test Immune Response
At the end of the 14 day experimental period, all pigs fed treatments 1, 2,
3, and 4 were subjected to a LPS challenge. The source of the LPS was
Escherichia coli O111:B4 (Sigma-Aldrich, Co., St. Louis, MO). A rectal
temperature reading was taken for each of the pigs. The pigs were then injected
intraperitoneally with 25 µg LPS (suspended in 9 g/L saline) per kg of body
weight (0 hr). In addition to 0 hour sampling, temperature readings and blood
collections were taken at hours 1.5, 3.0, and 6.0. All of the blood samples were
placed on ice after collection and then in a refrigerator overnight. The blood
samples were centrifuged for 10 min. at 3,000 x g and 1-2°C to recover the
serum as described previously. Each serum sample was then transferred to
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appropriately labeled cryovials. The serum was held in a freezer (-20°C) until
immunoglobulin analyses were performed.
Immunoglobulin Analyses
The serum samples were analyzed for the immunoglobulins IgM, IgA, and
IgG. An enzyme linked immunosorbent assay (ELISA) quantitation kit for each
immunoglobulin was used (Bethyl Laboratories, Inc., Montgomergy, TX). The
serum was analyzed according to the manufacturer’s directions.
Statistical Analysis
The serum cholesterol data were analyzed using a repeated measures
analysis of covariance (ANCOVA) with the SAS software (SAS Institute, 2003).
Day 0 cholesterol values were used as a covariate. Subgrouping of treatments
allowed for the adequate modeling of the variance. The subgroups were as
follows: treatments 1 and 2, treatments 3 and 4, and treatments 5 and 6. Fit
statistics were used to pick the best model. The compound symmetry covariance
structure was adopted.
The immunoglobulin data for IgG, IgA, and IgM levels were analyzed
using a repeated measures analysis with the SAS software (SAS Institute, 2003).
For both IgG and IgA an analysis of covariance (ANCOVA) was modeled with
time 0 as a covariate. There was no significant covariate effect for time 0 in the
IgM data. An analysis of variance (ANOVA) was used for the IgM data. Fit
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statistics were analyzed and the Toeplitz covariance structure was adopted for
IgG, IgA, and IgM analysis.
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Table 1. Composition of diet used in pig feeding trial
aVitamin and mineral mix (Oklahoma State University, Stillwater,
OK)
bAfter mixing with a Marion mixer (Rapids Machinery Co., Marion,
Iowa), 68.18 kg of feed was removed for the adjustment feeding period.
436.3 g of crystalline cholesterol (approx. 95% GC; Sigma Chemical Co.,
St. Louis, Mo.) was added and mixed into the remaining 272.31 kg of feed
for used in the experimental period.
Component Amount (kg)
Corn grain 119.70
Soybean meal (48% CP) 118.89
Whey, dried 68.18
Butter 25.57
Calcium phosphate (dicalcium) 2.86
Limstone, ground 3.16
Sodium chloride 0.85
OSU Trace Mineral mixa 0.51





The identities of L. acidophilus RP32 (ATCC 43121) and S. thermophilus
OSU-1 were confirmed as described in the 9th edition of Bergey’s Manual of
Determinative Bacteriology (Sneath et al., 1986). Lactobacillus acidophilus RP32
(ATCC 43121) is a Gram positive, catalase negative, nonsporeforming rod.
Streptococcus thermophilus OSU-1 is a Gram positive, catalase negative, cocci.
(The complete culure identification characteristics for these cultures are listed in
Table 3 and Table 4 respectively in the Appendix.) 
Influence of Oatwell 22 β-glucan on Cholesterol Assimilation and Bile Salt
Deconjugation
The Oatwell 22 β-glucan solution did not enhance cholesterol assimilation
by L. acidophilus RP32 as was hoped (Table 5 in the Appendix). The values
obtained with and without the β-glucan were virtually the same.
The values obtained for the deconjugation of bile salts with and without
the β-glucan solution were also very similar (Table 6 in the Appendix). There
was a slight decrease in the amount of cholic acid released from sodium
taurocholate with added β-glucan.
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Feeding Trial
All of the pigs were healthy throughout the duration of the feeding trial.
The day 0 cholesterol values for all groups were highly variable. The starting
cholesterol values across groups ranged from 90.5 mg/dl to 118.25 mg/dl. There
was also a lot of variability among animals within treatments. All of the variability
made the data difficult to analyze. The changes in total serum cholesterol from
day 0 of the trial are illustrated in Figure 1. The mean levels of cholesterol
decreased in the group receiving the control milk containing added lactobacilli
and did not increase for the group receiving the fermented milk plus lactobacilli.
However, it increased in all other treatment groups.
The cholesterol data were analyzed using subgrouping in order to
adequately model the variance. The subgrouping was organized as follows:
treatments 1 and 2, treatments 3 and 4, and treatments 5 and 6. The data were
analyzed using a repeated measures analysis of covariance with day 0
cholesterol values as a covariate. There was no overall treatment effect
(p=0.7017). There also was no overall day effect (p=0.9846) or trt*day effect
(p=0.0788). The only significant effect was an initial cholesterol (day 0
values)*trt*day effect (p=0.0439). The initial cholesterol of the pigs had a
significant impact on the cholesterol response to the treatments and high
cholesterol diet. In order to compare the treatments the baseline cholesterol
values were grouped to low, middle, or high serum cholesterol levels. The
grouping values are as follows: low 85 mg/ml, middle100 and 115 mg/dl, and a
high 130 mg/dl. The least squares means of trt*day at each initial value were
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computed. A slice effect for both treatment and day was used to determine
significant differences among treatments and within treatments for day 7 and day
14.
The results for the effect of all treatments on total serum cholesterol at
adjusted baseline values for 85, 100, 115, and 130 mg/dl are summarized in
Table 7 in the Appendix. There were no overall significant treatment effects for
day 7 or day 14 cholesterol values when adjusted for a low initial cholesterol level
of 85 mg/dl, medium values of 100 or 115 mg/dl, or for an initial high cholesterol
level of 130 mg/dl. When adjusted for an initial cholesterol level of 85 mg/dl there
was a significant decrease in total serum cholesterol from day 7 to day 14 for
treatment 2 (control milk + L. acidophilus). For all other treatments there were no
significant differences between day 7 and day 14 total cholesterol values. There
were no significant differences between day 7 and day 14 cholesterol levels
when baseline was adjusted to 100 mg/dl. For the baseline adjustment of 115
mg/dl there were significant increases in cholesterol from day 7 to day 14 for
treatments 1 (control) and 2. There were no significant increases or decreases
for other treatments at this level. After the adjustment of baseline levels to 130
mg/dl there was a significant increase in cholesterol from day 7 to day 14 for
treatments 1 and 2. There were no significant increases or decreases for other
treatments at this level.
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Lipopolysaccharide Challenge and Immunoglobulin Levels
On day 14 of the feeding trial pigs in treatment groups 1, 2, 3, and 4 were
injected with lipopolysaccharide (LPS) derived for enteropathogenic E. coli
O111:B4. The serum levels for IgG, IgA, and IgM were measured as a means of
determining if the treatment influenced the immune response of the pigs. All of
the immunoglobulin data were analyzed with a repeated measures analysis.
Both IgG and IgA had significant covariate effect for initial immunoglobulin levels
so an analysis of covariance (ANCOVA) was conducted. The IgM did not have a
significant covariate effect for baseline levels so an analysis of variance
(ANOVA) was conducted. (The immunoglobulin results for IgA, IgG, and IgM are
summarized in Table 8 in the Appendix.)  
While there was a trend toward higher levels of IgA for the group(s)
receiving milk and lactobacilli overall there was no significant treatment effect
(p=0.0803). There were significant overall effects for initial IgA*treatment
(p=0.0002) and hour of blood sampling (p=0.0004). (The hour effects are
summarized in Table 9 in the Appendix.) Because of the significant covariate
effect of initial IgA values some adjustments were made for comparisons.
Baseline IgA levels were adjusted to 8, 10, and 12 mg IgA/ml serum. There were
some significant differences when baseline values were adjusted to 10 mg/ml.
The treatment 3 group had the highest IgA level of 11.20 mg/ml. The treatment 2
level of 11.00 mg/ml did not differ significantly from treatment 3 (p=0.6492) or the
control (treatment 1) level of 10.08 mg/ml (p= 0.0536). Treatment 4 resulted in
the lowest level of IgA at 9.62 mg/ml. When baseline was adjusted to 12 mg/ml
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treatment 3 had the highest IgA level of 13.50. Both treatments 1 and 2 did not
differ significantly from this level with their values of 12.10 (p=0.1380) and 13.05
(p=0.4341) mg/ml respectively, however treatment 4 had a significantly lower IgA
level of 10.79 mg/ml.
The changes from 0 hr for levels of IgA across hours are illustrated in
Figure 2. The increase in IgA levels for all treatments peaked at 1.5 hours.
Treatment 3 peaked at the highest level while treatment 2 was the next highest.
The control treatment had the lowest IgA level at 1.5 hours. The IgA levels
decreased for all treatments after 1.5 hours. Treatment 2 had the highest levels
at hours 3 and 6 with treatment 3 at the second highest. Treatment 4 dropped off
faster than the control.
For IgG there was no overall treatment effect (p=0.0743) or
treatment*hour effect (p=0.9004). There were significant effects for initial
IgG*treatment (0.0446) and hour of blood sampling (p=0.0022). (The hour
effects are summarized in Table 9 in the Appendix.) Baseline IgG values were
adjusted because of the significant covariate effect of initial IgG levels.
Comparisons were made from baseline adjustments to 15, 30, and 45 mg IgG/ml
serum. At the baseline adjustment of 45 mg/ml both treatments 2 and 3
exhibited the highest IgG levels of 43.92 and 37.72 mg/ml respectively. The IgG
levels of treatment 1 and 4 were significantly lower than those of treatments 2
and 3 whereas the levels for treatments 1 and 4 were not significantly different
from each other (p=0.2185).
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The changes from 0 hr for levels of IgG across hours are illustrated in
Figure 3. Treatment 3 had the highest IgG level that peaked at 1.5 hours.
Treatment 2 had the next highest levels. Treatment 4 decreased from hour 0
and was lower than the control treatment, which also decreased from hour 0.
For IgM there was no overall treatment effects (p=0.2337) or
treatment*hour effects (p=0.5430). There was a significant hour effect
(p=0.0038). (The hour effects are summarized in Table 9 in the Appendix.) No
significant covariate effect for initial IgM levels was observed so no baseline
adjustments were needed. Even though the values for treatments including the
lactobacilli tended to be higher than their respective controls, there were no
significant differences between the treatments for IgM levels.
The IgM level trends across hours are illustrated in Figure 4. All
treatments except for the control increase and showed a peak at 1.5 hours,
followed by a decrease, and then an increase to hour 6. The treatment 4 group
exhibited the highest IgM levels followed by treatments 2 and 3 which had similar
responses to one another. The control treatment group had the lowest IgM
levels.
Lipopolysaccharide Challenge and Pig Body Temperature
The body temperature of the pigs in the LPS challenge was taken initially
and at 1.5, 3.0, and 6.0 hours after the administration of the E. coli LPS. (The
temperature trends are illustrated in Figure 5 in the Appendix.) Temperatures for
all groups (treatments 1-4) appeared to peak at 3.0 hours. From 0 to 3.0 hours
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there was a steady increase. After 3.0 hours the temperatures decreased







































Figure 1. Changes in total serum cholesterol (mg/dl) from day 0 to in response to
experimental treatments. Treatment descriptions: 1) control milk, 2) control milk
+ L. acidophilus RP32, 3) control milk fermented with S. thermophilus OSU-1, 4)
control milk fermented with S. thermophilus OSU-1 + L. acidophilus RP32, 5) 5 g































Figure 2. Changes in serum IgA levels (mg/ml) in response to Escherichia coli
lipopolysaccharide challenge from hour 0 to 1.5, 0 to 3, and 0 to 6. Treatment
descriptions: 1) control milk, 2) control milk + L. acidophilus RP32, 3) control milk
fermented with S. thermophilus OSU-1, 4) control milk fermented with S.































Figure 3. Changes in serum IgG levels (mg/ml) in response to Escherichia coli
lipopolysaccharide challenge from hour 0 to 1.5, 0 to 3, and 0 to 6. Treatment
descriptions: 1) control milk, 2) control milk + L. acidophilus RP32, 3) control milk
fermented with S. thermophilus OSU-1, 4) control milk fermented with S.

































Figure 4. Changes in serum IgM levels (mg/ml) in response to Escherichia coli
lipopolysaccharide challenge from hour 0 to 1.5, 0 to 3, and 0 to 6. Treatment
descriptions: 1) control milk, 2) control milk + L. acidophilus RP32, 3) control milk
fermented with S. thermophilus OSU-1, 4) control milk fermented with S.
thermophilus OSU-1 + L. acidophilus RP32.
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DISCUSSION
The strain of L. acidophilus used for the present study was one used in
previous research in our laboratory because of several of its characteristics.
Lactobacillus acidophilus RP32 (ATCC 43121) was isolated from the intestine of
a pig and is bile tolerant. It can remove cholesterol from laboratory media by
assimilation and has also been shown to exert a hypocholesterolemic effect in
swine (Gilliland et al., 1985, De Rodas et al., 1996).
This study used young pigs for several reasons. The smaller size of a
young pig made for easier handling than a mature animal. It has also been
documented that hypercholesterolemia can be induced in young pigs more
readily than adult animals (Barnes et al., 1959; Ratcliffe and Luginbϋhl, 1971).
The pig has also been deemed a very acceptable model for both cardiovascular
and immunological applications (Ratcliffe and Luginbϋhl, 1971; Rothkötter et al.,
2002).
While there was no overall significant influence on serum cholesterol when
all animals in each group were included in the statistical analyses, the trend was
for lower levels in two out of three groups fed the lactobacilli. The exeption was
those on the feed supplemented with β-glucan.
The results obtained from the cholesterol feeding trial were highly variable
among animals. This presented a problem for data analysis because the high
variability was masking some of the trends that might be present. In order to
minimize the effects of the high variance, the data were divided into subgroups
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by treatments for statistical analysis. The subgroups are as follows: milk without
and with cells of L. acidophilus (treatments 1 and 2), fermented milk without and
with cells of L. acidophilus (treatments 3 and 4), and β-glucan plus milk without
and with cells of the lactobacilli (treatments 5 and 6). Subgrouping allowed for
the adequate modeling of the variance. There was a significant initial cholesterol
by treatment by day interaction. The data were analyzed with day 0 cholesterol
values as a covariate. In order to make comparisons the data was adjusted to
baseline cholesterol levels representing a low, two midway, and a high starting
cholesterol. The initial cholesterol had a significant impact on the outcome.
This revealed a significant decrease in serum cholesterol observed only from day
7 to day 14 for treatment group 2 in the low baseline (85 mg/dl) compared to the
control group (treatment 1). This culture has demonstrated cholesterol
assimilation (Gilliland et al., 1985; Noh et al. 1997) and bile salt deconjugation in
laboratory media (Gilliland et al., 1985; Corzo and Gilliland, 1999a.). The culture
of L. acidophilus exerted beneficial control of serum cholesterol levels in pigs fed
a high cholesterol diet (Gilliland et al., 1985; De Rodas et al., 1996). It is unclear
why there were no other significant differences besides the problem of variation
on the individual animal level. The young pigs used in the study by Gilliland et al.
(1985) had initial serum cholesterol levels ranging from 52 to 56 mg/dl and
exhibited less variability in the values. It was also found that the pigs in the
present study were slightly younger than those used in the 1985 study. This may
have also had some effect on the cholesterol results.
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Milk fermented with S. thermophilus OSU-1 (treatment 3) compared to the
fermented milk with added L. acidophilus RP32 (ATCC 43121) (treatment 4) did
not indicate any appreciable differences. The inclusion of the fermented milk to
the project was done because of the ability of exocellular polysaccharides (EPS)
formed by S. thermophilus OSU-1 to bind free bile acids. Pigeon et al. (2002)
studied several strains of L. delbrueckii ssp. bulgaricus and S. thermophilus that
produce EPS. The strains that produced the highest amounts of EPS were
tested for the ability to bind free bile acids. Streptococcus thermophilus OSU-1
was among those strains tested. It was able to bind the most cholic acid when
compared to the other two S. thermophilus strains tested.
In theory the bile salt binding ability of S. thermophilus OSU-1 may also
help to enhance the bile salt deconjugation of L. acidophilus RP32 (ATCC 43121)
by helping to control feedback inhibition. An accumulation of free bile salts
caused feedback inhibition of the bile salt hydrolase enzyme of L. acidophilus
(Corzo, 1997). This enzyme is responsible for the bile salt deconjugation by L.
acidophilus RP32 (ATCC 43121). Such activity in the gut may be partially
responsible for helping lower serum cholesterol.
Unfortunately neither treatment 3 nor 4 appeared to confer a significant
decrease in serum cholesterol. When baseline levels were adjusted to 130 mg/dl
there was a decrease in cholesterol from day 7 to day 14 for treatment 4 but it
was not significant. For treatment 3 the bile salt binding ability of S. thermophilus
OSU-1 may not have been high enough to realize a significant difference in an in
vivo system. The combination of S. thermophilus OSU-1 and L. acidophilus
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RP32 (ATCC 43121) did not exhibit the enhanced combined effect as was
hoped.
Treatment 5 was comprised of 5 g of oat bran fiber and control milk while
treatment 6 was similar but with the addition of L. acidophilus RP32 (ATCC
43121). These treatments were components of the study based on the ability of
oat bran to help lower serum cholesterol. Oat β-glucan can bind free bile acids
and result in the increased fecal excretion of bile acids (Kirby et al., 1981;
Anderson et al. 1991; Lia et al., 1995; Amundsen et al., 2003). There are several
other proposed cholesterol-lowering mechanisms for oat β-glucan. Colonic
microflora ferment oat bran to short chained fatty acids such as propionate
(Anderson et al. 1991) which can inhibit cholesterol synthesis in the liver (Wright
et al., 1990; Chen et al., 1984). Increased soluble fiber in the diet causes a
decrease in insulin secretion. This may decrease cholesterol synthesis because
insulin stimulates HMG-CoA reductase which is involved in the rate limiting step
of cholesterol formation in the liver (Jenkins et al., 1989). Increased gut viscosity
from oat bran also may form a barrier to deter bile acid reapsorption (Beer et al.,
1995).
There were no significant differences for either treatment 5 or 6. However
there were some statistically insignificant decreases. When the baseline
cholesterol was adjusted to 115 and 130 mg/dl there was a trend toward a slight
decrease in cholesterol from day 7 to day 14 for treatment 6. The optimum
amount of oat bran to consume to elicit positive health effects has not been
determined. We arrived at the amount of oat bran fed in this trial by observing
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amounts of oat bran fed in a variety of human studies. The estimated amount of
β-glucan fed to test subjects and their average weights were taken into account.
This led to an approximate amount to feed on a weight basis which was
extrapolated to the approximate weight of the pigs. Because of all of these
approximations we may have not incorporated enough oat bran into the diets of
treatment groups 5 and 6 to observe more obvious and significant cholesterol
lowering effects.
The immunoglobulins measured in this study are the main antibodies
present in blood, lymph, and connective tissue (Parham, 2000). The IgG aids
phagocytic cells in the engulfment of microorganisms and toxins. A bacterium
becomes opsonized by being coated with IgG and this causes a more efficient
destruction of the organism. During an immune response IgM is the first
antibody secreted. When IgM binds to the pathogen surface the complement
system is activated and the pathogen will be engulfed by macrophages. The IgA
binds to toxins and pathogens on mucosal surfaces. More IgA is made in the
gastrointestinal tract than other isotypes to protect the body from infection that
can accompany the uptake of food.
Pigs in treatment group 1, 2, 3, and 4 were subjected to an E. coli
O111:B4 lipopolysaccharide (LPS) challenge so that possible immune stimulating
effects of the probiotics could be tested. This particular LPS was used based on
previous research in the nutritional science and animal science departments at
Oklahoma State University (Mandali et al., 2000; Mandali et al., 2002). Pigs fed
cells of L. acidophilus (either in milk or fermented milk) tended to have higher
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levels of IgA than did the respective controls. However, overall the differences
were not significant. There was considerable variation in the immunoglobulin
data which may be the reason for lack of significant differences. Other studies
have reported variation in immunoglobulin levels of young pigs (DeBuysscher
and Berman, 1980). For analyses a baseline level adjustment into groups of 8,
10, and 12 mg/ml was used for IgA statistical analysis. Using this approach, for
the baseline of 10 mg/ml group the treatment 3 group exhibited the highest IgA
level of 11.2 mg/ml. Treatment 2 was the second highest at 11.00 mg/ml and
this was not significantly different from the treatment 3 result. The control
treatment (1) was not significantly different from treatment 2 or the IgA level for
treatment 4 which was statistically the lowest at 9.62 mg/ml.
Similar isolated significant differences were noted for IgG using this
statistical approach. However, we are not able to say, based on the data from
this study, that in general the consumption of cells of L. acidophilus exerts
significant impact on immunoglobulins. In the case of the fermented milk with
and without cells of the lactobacilli there was no trend for apparent differences.
This may be due to some sort of interaction between the cultures. Results from a
study by Perdigόn et al. (1988) revealed a diminished immune enhancement
when two cultures were combined in a treatment given to mice compared to the
individual cultures. In their study the two cultures were grown together in this
study. In the present study the milk was fermented with S. thermophilus OSU-1
and a concentrated culture of L. acidophilus RP32 (ATCC 43121) was added
after fermentation. There may have been unfavorable interactions between the
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two cultures in vivo that affected the immune enhancing capabilities. For future
research it may be necessary to investigate any interactions in vitro before a
combination is used.
A temperature reading was taken at the same time intervals as the blood
sampling. Temperatures for all treatment groups followed the same trend. There
was a steady increase and the peak temperatures occurred at 3.0 hours and
declined sharply by hour 6.0.
For future research on the enhancement of immunoglobulins it may be
beneficial to test other parameters. Webel et al. (1998) tested the effects of
vitamin E during an LPS challenge. The immune system markers tested were
interleukin-6 (IL-6) and plasma cortisol. The researchers justified this choice of
immune parameters because IL-6 is more effective than interleukin-1 (IL-1) or
tumor necrosis factor-α (TNF- α) for stimulating specific proteins in response to
inflammation. Plasma cortisol was chosen because it is elevated at the same
time as IL-6 after an LPS challenge.
It also may be beneficial to measure immunoglobulins specific to the
source of the challenge organism. Tejada-Simon et al. (1999) used a cholera
toxin to challenge mice being fed a yogurt containing L. acidophilus and
Bifidobacterium. Anti-cholera toxin IgA levels were tested in both fecal pellets
and blood serum. Link-Amster et al. (1994) measured both IgG and IgA titers
specific to their challenge organism, Salmonella typhi Ty21a. Measuring
immunoglobulins that are specific to the challenge organism may give a more
accurate description of what is occurring due to the experimental procedures.
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In the present study LPS from an enteropathogenic E. coli O111:B4 was
used to challenge the pigs. This organism and other enteric organisms cause
intestinal infections. It also may be of more benefit to measure intestinal
immunoglobulin levels. Link-Amster et al. (1994) concluded that the
consumption of fermented milk may increase the humoral immune response to
intestinal pathogens in the intestine. They used fecal immunoglobulins as a
measure of intestinal immunoglobulin levels.
In summary the present study shows some positive and some variable
results for the use of a probiotic culture and oat bran combinations to help control
hypercholesterolemia in pigs fed a high cholesterol diet. More research is
needed to adequately test the effects of the treatments without as much animal
to animal variability. It may be desirable to prescreen animals to select ones that
have less variable levels of serum cholesterol for use in the trials.
The treatments were more promising for the enhancement of immune
function. Both IgA and IgG levels were increased. Treatments 2 and 3 seemed
to confer the most immunological benefits. Further study is needed to investigate
the immune enhancing capabilities of L. acidophilus RP32 (ATCC 43121) and S.
thermophilus OSU-1. This type of research could lead to the development of
cultured products to aid in immune enhancement for humans.
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Table 2. Assignment of pigs to treatments for feeding trial

























aTreatment 1 = 25 ml 10% NFMS/day, Treatment 2 = 25 ml 10% NFMS +
L. acidophilus RP32/day, Treatment 3 = 25 ml 10% NFMS fermented with S.
thermophilus OSU-1/day, Treatment 4 = 25 ml 10% NFMS fermented with S.
thermophilus OSU-1 + L. acidophilus RP32/day, Treatment 5 = 25 ml 10% NFMS
+ 5 g Oatwell oat bran (on top of feed)/day, Treatment 6 = 25 ml 10% NFMS + L.
acidophilus RP32 + 5 g Oatwell oat bran (on top of feed)/day.
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Growth at 15°C - -
Growth at 45°C + +
1 Based on the API 50 CH system (bioMérieux sa, France). L. acidophilus RP32
(ATCC 43121) is a Gram positive catalase negative rod.
2 The reactions for Lactobacillus acidophilus are from the 9th edition of Bergey’s
Manual of Determinative Bacteriology.
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Table 4. Identification Streptococcus thermophilus by carbohydrate
fermentation1














1 Based on the API 50 CH system (bioMérieux sa, France). S. thermophilus
OSU-1 is a Gram positive catalase positive cocci that grows at 45°C and not at
15°C.
2 The reactions for Streptococcus thermophilus are from the 9th edition of
Bergey’s Manual of Determinative Bacteriology.
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Table 5. Influence of oatwell 22 β-glucan solution on cholesterol assimilation
of Lactobacillus acidophilus RP32 (ATCC 43121)
Treatment µg cholesterol removed1,2
416.67 µg/ml β-glucan 15.33 (1.53)
No β-glucan 14.67(1.53)
1Each value is a mean from three replications of the experiment;
numbers in parenthesis = standard deviation.
2µg of cholesterol removed were determined by subtracting the amount
of cholesterol in the spent broths from that in an uninoculated control; the
inoculated broth contained approximately 1,000 µg/ml.
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Table 6. Influence of β-glucan solution from Oatwell 22 on deconjugation of
taurocholate by Lactobacillus acidophilus RP32 (ATCC 43121)1
Sample Cholic acid released (µmoles/ml)




1Each value is a mean from three trials; during growth for 16 hr in MRS-
thio broth supplemented with 538 µg sodium taurocholate/ml.
2numbers in parenthesis = standard deviation.
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Table 7. Effect of treatments on total serum cholesterol of pigs fed a high
cholesterol diet
No significant differences were detected between treatments at each
baseline cholesterol level.
abResponse means within a column with the same letter are not
significantly different (p=0.05).
1Description of treatments – see Table 2 pg. 67
2Baseline value adjustment for treatment comparisons; numbers in
parentheses beneath the baseline value represent the range of values included





Day 1 2 3 4 5 6
7 109.19a 93.41a 101.56a 24.70a 104.83a 100.51a852
(79-102) 14 105.85a 79.75b 107.16a 63.94a 109.35a 107.37a
7 109.01a 91.15a 101.92a 66.79a 114.45a 102.53a1002
(86-114) 14 114.19a 94.28a 111.55a 87.42a 120.10a 103.64a
7 108.83b 88.89b 102.27a 108.88a 124.07a 104.55a1152
(86-114) 14 122.54a 108.81a 115.93a 110.91a 130.85a 99.90a
7 108.65b 86.63b 102.62a 150.97a 133.70a 106.56a1302
(102-136) 14 130.88a 123.35a 120.32a 134.40a 141.60a 96.17a
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Table 8. Serum immunoglobulin levels for pigs challenged with
lipopolysaccharide (LPS) from E. coli O111:B4
abc Response means within a column with the same letter are not
significantly different (p=0.05).
1Treatment descriptions – see Table 2 on pg. 67
2Baseline value adjustment for treatment comparisons.
3Values are least squares estimates; Numbers in parenthesis = standard
error.
IgA (mg/ml)
Trt1 IgA0 = 8
2,3 IgA0 = 10
2,3 IgA0 = 12
2,3
1 8.07a (0.52) 10.08bc (0.55) 12.10ab (0.75)
2 9.02a (0.56) 11.00ab (0.51) 13.05a (0.59)
3 8.89a (0.55) 11.20a (0.52) 13.50a (0.66)
4 8.45a (0.53) 9.62c (0.51) 10.79b (0.51)
IgG (mg/ml)
Trt IgG0 = 15
2,3 IgG0 = 30
2,3 IgG0 = 45
2,3
1 20.14a (5.71) 23.48ab (4.08) 26.83b (4.47)
2 10.66a (5.73) 27.29a (3.96) 43.92a (5.92)
3 12.84a (5.51) 25.28ab (4.07) 37.72a (4.39)
4 19.40a (4.58) 21.19b (4.09) 22.99b (3.96)







Table 9. Hour effects for changes in serum immunoglobulins.
Immunoglobulins (mg/ml)
Hour1 IgA2 IgG2 IgM2
03 9.75 35.38 1.99b (0.16)
1.5 11.41a (0.53) 35.79a (4.56) 2.42a (0.16)
3 10.42b (0.53) 30.19a (4.56) 1.75b (0.16)
6 8.92c (0.53) 16.15b (4.56) 2.26a (0.16)
1Hour of blood collection for immunoglobulin analysis.
2Least squares means estimate; the numbers in parentheses are standard
errors.
3Hour 0 averages are included. The least squares means estimates for
hour 0 for IgA and IgG are not available because hour 0 was a covariate in the
analysis.

























Figure 5. Changes in pig body temperature in response to Escherichia coli
lipopolysaccharide challenge. Treatment descriptions: 1) control milk, 2) control
milk + L. acidophilus RP32, 3) control milk fermented with S. thermophilus OSU-
1, 4) control milk fermented with S. thermophilus OSU-1 + L. acidophilus RP32.
Table 10. Influence of treatments 1 and 2 on serum cholesterol (mg/dl) in pigs fed a high cholesterol diet (raw data)
1a 2a
Day 0 Day 7 Day 14 Day 0 Day 7 Day 14
125 103 125 83 100 81
82 109 104 98 73 81
116 116 127 115 85 104
81 108 103 108 106 115
Means 101 109 114.75 101 91 92.25
aSee footnote of Table 2 on pg. 67 for treatment descriptions.
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Table 11. Influence of treatments 3 and 4 on serum cholesterol (mg/dl) in pigs fed a high cholesterol diet (raw data)
3a 4a
Day 0 Day 7 Day 14 Day 0 Day 7 Day 14
84 128 111 111 104 104
102 138 129 117 119 100
98 62 89 109 83 112
88 79 109 136 166 148
Means 93 101.75 109.5 118.25 118 116
a See footnote of Table 2 on pg. 67 for treatment descriptions.
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Table 12. Influence of treatments 5 and 6 on serum cholesterol (mg/dl) in pigs fed a high cholesterol diet (raw data)
5a 6a
Day 0 Day 7 Day 14 Day 0 Day 7 Day 14
113 151 153 79 108 126
101 127 129 91 103 94
72 81 88 111 104 106
133 111 124 81 90 98
Means 104.75 117.5 123.5 90.5 101.25 106
a See footnote of Table 2 on pg. 67 for treatment descriptions.
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Table 13. Influence of treatments on serum HDL cholesterol (mg/dl) in pigs fed a high cholesterol diet
1a 2a
Day 0 Day 7 Day 14 Day 0 Day 7 Day 14
49 36 47 40 36 31
35 33 33 47 32 36
43 36 44 42 28 40
27 30 31 41 32 38
Means 38.5 33.8 38.8 42.5 32.0 36.3
3a 4a
Day 0 Day 7 Day 14 Day 0 Day 7 Day 14
33 38 35 51 52 47
40 46 47 39 55 51
46 20 31 56 49 62
34 21 31 72 99 87
Means 38.3 31.3 36.0 48.3 40.8 42.5
5a 6a
Day 0 Day 7 Day 14 Day 0 Day 7 Day 14
46 51 56 34 33 40
39 35 42 36 29 31
31 31 34 43 35 37
51 32 41 34 31 33
Means 41.8 37.3 43.3 36.8 32.0 36
aTreatment descriptions – see Table 2 pg. 67.
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Table 14. Influence of treatments on serum LDL cholesterol (mg/dl) in pigs fed a high cholesterol diet
1a 2a
Day 0 Day 7 Day 14 Day 0 Day 7 Day 14
67 59 65 31 53 38
35 55 61 35 32 31
60 68 70 64 47 54
45 66 64 50 66 65
Means 51.8 62.0 65.0 45.0 49.5 47.0
3a 4a
Day 0 Day 7 Day 14 Day 0 Day 7 Day 14
43 79 65 46 40 44
50 76 73 55 42 38
38 35 51 42 28 40
42 49 67 50 53 48
Means 43.3 59.8 64.0 54.5 63.8 61.8
5a 6a
Day 0 Day 7 Day 14 Day 0 Day 7 Day 14
51 85 76 32 63 74
42 76 76 43 61 55
29 44 43 52 64 58
72 72 74 35 52 58
Means 48.5 69.3 67.3 40.5 60.0 61.3
aTreatment descriptions – see Table 2 pg. 67.
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Table 15. Influence of treatments on serum triglycerides (mg/dl) in pigs fed a high cholesterol diet
1a 2a
Day 0 Day 7 Day 14 Day 0 Day 7 Day 14
45 36 65 58 56 58
59 104 46 75 46 68
67 61 64 49 51 52
42 60 40 87 40 57
Means 53.3 65.3 53.8 67.3 48.3 58.8
3a 4a
Day 0 Day 7 Day 14 Day 0 Day 7 Day 14
45 58 56 72 57 62
60 78 49 116 106 56
69 34 37 58 28 48
60 45 57 68 72 63
Means 58.5 53.8 49.8 78.5 65.8 57.3
5a 6a
Day 0 Day 7 Day 14 Day 0 Day 7 Day 14
79 69 105 65 61 60
100 79 59 62 60 44
61 30 52 81 31 54
53 36 44 59 36 38
Means 73.3 53.5 65.0 66.8 47.0 49.0
aTreatment descriptions – see Table 2 pg. 67.
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Table 16. Average daily gain, feed intake, and feed efficiency of pigs recorded













1 3 7.03 0.66 0.50 1.32
1 5 5.82 0.62 0.42 1.48
1 20 6.71 0.68 0.48 1.42
1 24 5.99 0.64 0.43 1.49
Avg. 6.39 0.65 0.46 1.41
2 1 6.53 0.66 0.47 1.40
2 11 6.71 0.61 0.48 1.27
2 14 6.98 0.65 0.50 1.30
2 18 6.17 0.66 0.44 1.50
Avg. 6.60 0.64 0.47 1.36
3 2 6.45 0.67 0.46 1.46
3 4 6.53 0.64 0.47 1.36
3 13 7.31 0.67 0.52 1.29
3 17 6.94 0.70 0.50 1.40
Avg. 6.81 0.67 0.49 1.37
4 9 6.94 0.64 0.50 1.28
4 10 5.26 0.55 0.38 1.45
4 19 7.78 0.70 0.56 1.25
4 22 6.44 0.66 0.46 1.43
Avg. 6.61 0.64 0.47 1.36
5 6 5.53 0.64 0.40 1.60
5 7 4.85 0.57 0.35 1.63
5 21 6.94 0.67 0.50 1.34
5 23 7.12 0.70 0.51 1.37
Avg. 6.11 0.64 0.44 1.45
6 8 5.85 0.59 0.42 1.40
6 12 6.30 0.56 0.45 1.24
6 15 7.62 0.70 0.54 1.30
6 16 7.03 0.62 0.50 1.24
Avg. 6.70 0.61 0.48 1.27
a See footnote of Table 2 on pg. 67 for treatment descriptions.
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Table 17. Weights of pigs recorded during feeding of a high cholesterol diet
Weight (kg)
Treatmenta Pen # Day 0 Day 7 Day 14 Weight
gain
1 3 10.93 14.38 17.96 7.03
1 5 8.60 11.34 14.42 5.82
1 20 10.39 13.79 17.10 6.71
1 24 9.89 12.88 15.88 5.99
Avg. 9.95 13.10 16.34 6.39
2 1 8.94 11.97 15.47 6.53
2 11 10.07 13.79 16.78 6.71
2 14 10.57 13.65 17.55 6.98
2 18 10.39 13.38 16.56 6.17
Avg. 9.99 13.20 16.59 6.60
3 2 10.02 13.34 16.47 6.45
3 4 8.94 11.97 15.47 6.53
3 13 10.70 14.24 18.01 7.31
3 17 10.02 13.52 16.96 6.94
Avg. 9.92 13.27 16.73 6.81
4 9 9.89 13.43 16.83 6.94
4 10 8.98 11.11 14.24 5.26
4 19 10.82 14.97 18.60 7.78
4 22 10.07 13.34 16.51 6.44
Avg. 9.94 13.21 16.55 6.61
5 6 9.48 11.84 15.01 5.53
5 7 9.66 11.84 14.51 4.85
5 21 9.75 13.15 16.69 6.94
5 23 11.07 14.70 18.19 7.12
Avg. 9.99 12.88 16.10 6.11
6 8 9.84 12.29 15.69 5.85
6 12 9.53 11.79 15.83 6.30
6 15 11.16 15.06 18.78 7.62
6 16 9.12 12.25 16.15 7.03
Avg. 9.91 13.03 16.61 6.70




























Figure 6. Effect of oatwell 22 oat bran β-glucan on the growth of Lactobacillus
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